Rachel Haurwitz

Mar 8

Co-Founder and CEO of Caribou Biosciences

Rachel co-founded Caribou Biosciences and serves as the gene-editing company’s President and CEO. Her company focuses on CRISPR-based technologies. Rachel has an impressive educational background having studied at Harvard and the University of California, Berkeley, and she holds several patents in her field.

Her most recent news as of March 3, 2021—her company just closed Series C funding of $115M! The funding will advance their CRISPR technology platform and evolve cell therapies focused on cancer treatment

Powerful Quotes by a Powerful Woman

“I’m not sure if I face more discrimination because of my age or my gender.”

“I am here because I was in the right place at the right time, with the right people and the right science around me.”

“I have, multiple times, been in a boardroom with a bunch of VCs who are proudly going through their deck of who their team is … and at some point they’ll be about halfway through the slides and freeze because they realize they’re showing me a slide of [only] men.”